journal article Mar 01, 2002

Nedocromil sodium ophthalmic solution 2% twice daily in patients with allergic conjunctivitis

View at Publisher Save 10.1007/bf02850056
Topics

No keywords indexed for this article. Browse by subject →

References
16
[1]
Reiss J, Abelson MB, George MA, Wedner HJ. Allergic conjunctivitis. In: Pepose JS, Holland GN, Wilhelmus KR, eds.Ocular Infection and Immunity. St. Louis, Mo: Mosby-Year Book Inc; 1996: 347–358.
[2]
Nathan R, Meltzer E, Silner J, Storms W. Prevalence of allergic rhinitis in the United States.J Allergy Clin Immunol. 1997;99:S808-S814. 10.1016/s0091-6749(97)80040-1
[3]
Bielory L. Allergic and immunologic disorders of the eye, Part I: immunology of the eye.J Allergy Clin Immunol. 2000;106(5, pt 1):805–816. 10.1067/mai.2000.111029
[4]
Bacon AS, Ahluwalia P, Irani AM, et al. Tear and conjunctival changes during the allergeninduced earlyand late-phase responses.J Allergy Clin Immunol. 2000;106(5, pt 1):948–954. 10.1067/mai.2000.110930
[5]
Bonini S, Vecchione A, Naim DM, Allansmith MR, Balsano F. Inflammatory changes in conjunctival scrapings after allergen provocation in humans [see comments].J Allergy Clin Immunol. 1988; 82(3, pt 1):462–469. 10.1016/0091-6749(88)90020-6
[6]
Corin RE. Nedocromil sodium: a review of the evidence for a dual mechanism of action.Clin Exp Allergy. 2000;30:461–468. 10.1046/j.1365-2222.2000.00769.x
[7]
Blumenthal M, Casale T, Dockhorn R, et al. Efficacy and safety of nedocromil sodium ophthalmic solution in the treatment of seasonal allergic conjunctivitis.Am J Ophthalmol. 1992;113:56–63. 10.1016/s0002-9394(14)75754-x
[8]
Kjellman NI, Stevens MT. Clinical experience with Tilavist: an overview of efficacy and safety.Allergy. 1995;50:14–22; discussion 34–38. 10.1111/j.1398-9995.1995.tb04252.x
[9]
Leino M, Carlson C, Jaanio E, et al. Double-blind group comparative study of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis.Ann Allergy. 1990;64:398–402.
[10]
Melamed J, Schwartz RH, Blumenthal MN, Zeitz HJ. Efficacy and safety of nedocromil sodium 2% ophthalmic solution b.i.d. in the treatment of ragweed seasonal allergic conjunctivitis.Allergy Asthma Proc. 2000;21:235–239. 10.2500/108854100778248863
[11]
Moller C, Berg IM, Berg T, Kjellman M, Stromberg L. Nedocromil sodium 2% eye drops for twice-daily treatment of seasonal allergic conjunctivitis: a Swedish multicentre placebocontrolled study in children allergic to birch pollen.Clin Exp Allergy. 1994;24:884–887. 10.1111/j.1365-2222.1994.tb01811.x
[12]
Stockwell A, Easty DL. Group comparative trial of 2% nedocromil sodium with placebo in the treatment of seasonal allergic conjunctivitis.Eur J Ophthalmol. 1994;4:19–23. 10.1177/112067219400400104
[13]
Alexander M, Rosen LJ, Yang WH. Comparison of topical nedocromil sodium and oral terfenadine for the treatment of seasonal allergic conjunctivitis.Clin Ther. 1999;21:1900–1907. 10.1016/s0149-2918(00)86738-7
[14]
Ciprandi G, Buscaglia S, Cerqueti PM, Canonica GW. Drug treatment of allergic conjunctivitis. A review of the evidence.Drugs. 1992;43:154–176. 10.2165/00003495-199243020-00003
[15]
Juniper EF. Rhinitis management: the patient’s perspective.Clin Exp Allergy. 1998;28(suppl 6): 34–38. 10.1046/j.1365-2222.1998.0280s6034.x
[16]
Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire.J Allergy Clin Immunol. 1999;104(2, pt 1):364–369. 10.1016/s0091-6749(99)70380-5
Metrics
6
Citations
16
References
Details
Published
Mar 01, 2002
Vol/Issue
19(2)
Pages
73-84
License
View
Cite This Article
Joseph Tauber (2002). Nedocromil sodium ophthalmic solution 2% twice daily in patients with allergic conjunctivitis. Advances in Therapy, 19(2), 73-84. https://doi.org/10.1007/bf02850056